Sunscreen Firm Warned, Natural Balms Among Recent Recalls: Consumer Health News
Executive Summary
Korean OTC firm Seidni has GMP, sunscreen labeling problems; DXM abuse by teens remains at 3%, annual survey shows; GMP deviations among reasons behind recent OTC recalls.
You may also be interested in...
States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.